Amarnath Singh
Researcher
Also affiliated: Babu Banarasi Das University (2015–2021); The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (2022–2025); Winthrop Rockefeller Foundation (2026); Arkansas Department of Health (2025); The Ohio State University (2022–2026); Council of Scientific and Industrial Research (2006–2015); Indian Institute of Toxicology Research (2006–2021); Academy of Scientific and Innovative Research (2019)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Amarnath Singh's research focuses on environmental exposures and their health impacts, with a particular emphasis on respiratory diseases and toxicological assessments. He has investigated the effects of polyaromatic hydrocarbons (PAHs) on human health, employing techniques like dispersive liquid-liquid microextraction for marker compound analysis in exposed individuals. His work also addresses chronic obstructive pulmonary disease (COPD) in women, specifically examining its link to indoor biomass burning through meta-analysis.
Singh's research portfolio extends to emerging environmental concerns, including the health implications of microplastics and nanoplastics. He has also explored metabolomics approaches for biomarker identification in various health contexts, such as doxorubicin-induced cardiotoxicity and adolescent body mass. His scholarship metrics include an h-index of 12, with 29 total publications and 777 citations. Singh collaborates with researchers at the University of Arkansas for Medical Sciences, including Ping-Ching Hsu, Renny S. Lan, Se‐Ran Jun, and Marjan Boerma.
Metrics
- h-index: 13
- Publications: 29
- Citations: 789
Selected Publications
-
Metabolic phenotypes of doxorubicin-induced cardiotoxicity among patients with breast cancer (2026)
-
DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy (2025)
-
A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity (2025)
Collaboration Network
Top Collaborators
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy
- DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy
- DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy
Similar Researchers
Based on overlapping research topics